In this episode, I'm speaking with Jose Munoz, who is the co-founder and managing director

of WonderMed, a health tech company empowering the inner healer of people through psychedelic medicine.

And this is one of the big emerging companies in the space around ketamine-assisted psychotherapy,

which has some amazing groundbreaking research coming out around depression in particular,

but also a number of other emerging conditions.

And this is a field that is just exploding with research and also exploding with changes in the

regulatory environment, not only of studying these compounds scientifically, which of course has

expanded massively in the last decade or so after

several decades of being illegal to study. And now we have changes in the regulatory environment

for clinical practice that are allowing the emergence of psychedelic-assisted psychotherapies, ketamine being the big one

that is available now, and MDMA-assisted psychotherapy, which has incredible research coming out

around treating post-traumatic stress disorders, for example, in war veterans, healing effects

that are unparalleled, unmatched by any other medicine or treatment

to date. We're seeing just extraordinary effects from this approach to healing. And Jose

Munoz's company, WonderMed, is one of the companies that is leading the way in this psychedelic

renaissance,

this revolution around psychedelic-assisted psychotherapy.

And we have a fascinating conversation,

and I think you'll get a lot of insights into this topic.

And one little quick thing before you get into this,

if you're somebody who's turned off by this whole topic and you think of psychedelics as just drugs and I don't want to listen to any crazy talk about those weird drugs and those are just people trying to escape reality and, you know, they're addicts and all this kind of judgment.

Maybe pull back that judgment for just a moment, maybe a little

...